Achison Inc Cl A News
Alexion Pharmaceuticals to Acquire Achillion in $930 Million Deal
Alexion is seeking to expand its pipeline of rare disease treatments through the acquisition.
Achillion Pharma Stock Soars as New Drug Gets FDA Breakthrough Status
Formerly an orphan-drug designee, Danicopan treats PNH, a rare acquired blood disease.
Johnson & Johnson Shuts Insulin Pump Business, Inks Other Deals
Healthcare giant Johnson & Johnson cut costs by laying off 297 staffers tied to its insulin pump business, while also buying a German surgical software company and inking a deal with biotech company targeting hepatitis B treatments.
S&P Reaches New Record as Stocks Rally Amid Subsiding Irma, North Korea Fears
Wall Street starts the week with a rally.
Dow, S&P 500 on Track for Best Day in 6 Months as Irma Worries Ease
The Dow is up more than 250 points.
Dow Trades Above 22,000 as Irma's Damage Estimates Lower Than Feared
Wall Street moves higher.
Achillion Shares Are Crashing on Termination of Hepatitis C Pact
The New Haven, Conn.-based firm on Sept. 9 received a termination notice regarding its license and collaboration pact with Johnson & Johnson's Janssen Pharmaceuticals Inc. on hepatitis C.
Achillion Pharmaceuticals Stock Falls, Baird Downgrades Over Lack of Confidence
Thursday's downgrade is in part based on a lack of confidence in Achillion's CH-4471 to compete with Alexion Pharmaceuticals' Soliris treatment.
These Two Biotech Stocks Are Going Berserk on Wednesday
And then there is Mylan.
Trading 5 Hot Charts Set to Break Out Soon for Profit
Here's how to potentially rake in some fat profits off a number of hot breakout setups.
How Airlines May Revive Fast Air Travel at More Reasonable Price
American Airlines is buying 20 supersonic jets from Boom Supersonic.
Taking Social Security? Retirees May Get a Big COLA Bump Up in 2023.
U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.
Wendy's Follows McDonald's in Making a Huge Change
Restaurants are moving to adapt to customers with very different wants and desires.